Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Oxford Molecular, Yamanouchi to codevelop ion channel modulators

April 26, 1996

RMP-7 advances to phase I/II in Europe

April 26, 1996

SIBIA, Ciba-Geigy extend drug discovery agreement

April 26, 1996

Roche licenses access to LIFESEQ database

April 26, 1996

SIBIA, Salk Institute expand agreement for NAChRs

April 26, 1996

GS-2888, permeation enhancer reported by Gilead, Glaxo Wellcome

April 19, 1996

Signal, Tanabe Seiyaku to collaborate on drug discovery

April 19, 1996

Pharmacopeia will collaborate with Daiichi for drug discovery

April 12, 1996

RMP-7 phase II trials initiated

April 12, 1996

Sequana, Aurora establish drug discovery collaboration

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...